- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02967406
Impact of Lifestyle Modification on the Development of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population
Impact of Lifestyle Modification on Prevention of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population: Cluster Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a community-based cluster randomized control trial aimed to investigate the impact of lifestyle modification (diet, physical activity, alcohol drinking and smoking) on the development of dementia, diabetes, chronic kidney disease, cancers, chronic obstructive pulmonary disease and cardiovascular disease in an intermediate risk population in mixed urban-rural areas of Ubon Ratchathani.
Objectives:
- examine the impact of lifestyle modification on the development of dementia, diabetes, chronic kidney disease, cancers, chronic obstructive pulmonary disease and cardiovascular disease in an intermediate risk population in Ubon Ratchathani
- examine the economic impact of lifestyle modification on prevention of dementia, diabetes, chronic kidney disease, cancers, chronic obstructive pulmonary disease and cardiovascular disease in an intermediate risk population in Ubon Ratchathani
Study design: community-based cluster randomized control trial
Setting: 60 villages randomly selected from mixed urban-rural areas in 15 districts of Ubon Ratchathani province.
Study population: 3,600 apparently healthy men and women aged 45-75 years who have resided in the village selected for at least one year. 4,000 men and women will be approached and screened.
Screening and baseline assessment:
After community consent, potential participants will be informed about the details of the project. For those who are willing to participate, written informed consent will be given before carrying out all research procedures. Participants will be questioned about their demographic characteristics, medical and family history, health behaviours including diet, physical activity, alcohol drinking and smoking. Physical activity will be assess using the Global Physical Activity Questionnaire (GPAQ) and diet will be assessed using 24 hour food recall. Their cognitive function will be assessed using the Mini-Mental State Exam (MMSE), Thai version, and clock drawing test and depression test will also be performed. Physical examination includes weight, height, blood pressure, waist and hip circumference as well as physical fitness test.
Fasting blood samples will be collected for the following laboratory tests: Complete blood count, creatinine, estimated glomerular filtration rate (eGFR), fasting plasma glucose, glycated haemoglobin (HbA1c), total cholesterol, triglyceride, HDL and estimated LDL-cholesterol, serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), thyroid stimulating hormone (TSH), Ca++, PO4-, urine creatinine/albumin, urine sodium & potassium.
Interventions:
Participants in 30 villages in the intervention group will be given 4x4 lifestyle modification intervention, which will address four health behaviors (diet, physical activity, alcohol drinking and smoking) at four different levels: individual, household, knowledge management and community levels. A new computer program called 'iActive' will be used. The program was adapted from the GPAQ with add-on functions to allow real-time assessment and presentation of the energy expenditure along with recommendations specific to each individual. Dietary counseling will be given individually following assessment using a new dietary assessment program called Dietary Assessment Scanning Calculator (DISC). Home visit will be done every 3 months by responsible nurses and village health volunteers in order to assess and give simple counseling about health behaviors. Knowledge management will be undertaken through meetings and forums between participants and villages with support from trained nurses. Situation analysis and agreed community action will be encouraged to address community problems concerning four health behaviors. A combination of these intensive interventions will be given for 3 years.
Follow-up and outcome ascertainment:
Participants will be followed at 1, 2, 5 and 10 years after baseline assessment for the development of the outcomes of interest. In each follow-up, procedures identical to baseline assessment will be done.
Primary outcome: Incident dementia Incident dementia will be ascertained by a battery of screening test (MMSE, clock drawing and depression tests) and those with abnormal test results will be referred to neuro-medicine specialists at the regional hospital for further investigations and diagnosis.
Secondary outcomes:
- Type 2 diabetes mellitus
- chronic kidney disease
- cancers
- chronic obstructive pulmonary disease
- cardiovascular disease
- body mass index
- waist circumference
- blood pressure
- Fasting plasma glucose
- HbA1c
- Lipids (total cholesterol, triglyceride, HDL and estimated LDL)
Tertiary outcomes:
- MMSE scores or Cognitive decline
- Alzheimer's disease
- Physical activity levels
- Dietary intake
- prevalence of current smokers
- prevalence of alcohol consumption
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ubon Ratchathani
-
Muaeng, Ubon Ratchathani, Thailand, 34000
- Sanpasitthiprasong Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Thai nationality
- Age 45-75 years
- Have resided in the Ubon Ratchathani's villages for at least 1 year
- Those giving written informed consent to participate in the research project
Exclusion Criteria:
- Known case of dementia, chronic kidney disease, diabetes, chronic obstructive pulmonary disease, cancers and cardiovascular disease
- Unable to communicate well in Thai
- Unable to move or get physical exercise
- Those at risk of having complications from performing physical exercise
- Those diagnosed with cancers of any system/ organ or those in the end of life period
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lifestyle modification
4 x 4 lifestyle modification intervention, addressing four health behaviors including physical activity, diet, smoking and alcohol drinking, at four different levels, i.e. individual, household, group/ knowledge management, and community levels
|
Participants in the intervention group will be given 4x4 lifestyle modification intervention, which will address four health behaviors (diet, physical activity, alcohol drinking and smoking) at four different levels: individual, household, knowledge management and community levels.
A new computer program called 'iActive' adapted from the GPAQ with add-on functions to allow real-time assessment and presentation of the energy expenditure along with recommendations specific to each individual will be used.
Dietary counseling will be given individually following assessment using a new dietary assessment program called Dietary Assessment Scanning Calculator.
Home visit will be done every 3 months by responsible nurses and village health volunteers.
Knowledge management will be done through meetings between participants and villages with support from trained nurses.
Situation analysis and community action will be encouraged to address four health behaviors.
|
No Intervention: Control
No special intervention will be given.
Prevention and treatment in normal practice is allowed
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dementia
Time Frame: 10 years
|
Number of participants with dementia.
Incident dementia will be diagnosed by medical specialists (Neuro-Med) following a battery of screening tests, including mini-mental state exam, depression and clock drawing tests.
|
10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Type 2 diabetes mellitus
Time Frame: 3, 5 and 10 years
|
Number of participants with type 2 diabetes mellitus.
Diabetes mellitus is biochemically and clinically diagnosed.
|
3, 5 and 10 years
|
Cardiovascular disease
Time Frame: 5 and 10 years
|
Number of participants with cardiovascular disease.
Clinical diagnosis of cardiovascular disease.
Diagnostic information will be obtained from medical records review and service reimbursement data.
|
5 and 10 years
|
Cancers
Time Frame: 5 and 10 years
|
Number of participants with cancers.
Diagnostic information will be obtained from medical records review and service reimbursement data.
|
5 and 10 years
|
Chronic obstructive pulmonary disease
Time Frame: 5 and 10 years
|
Number of participants with physician-diagnosed chronic obstructive pulmonary disease.
Diagnostic information will be obtained from medical records review and service reimbursement data.
|
5 and 10 years
|
Mortality
Time Frame: 5 and 10 years
|
All-cause mortality retrieved from death certificate database, which captures deaths nationwide, dates of death and related causes.
|
5 and 10 years
|
Blood sugar
Time Frame: 1, 2, 5 and 10 years
|
Blood sugar assessed as fasting plasma glucose and glycated hemoglobin (HbA1c)
|
1, 2, 5 and 10 years
|
Blood lipids
Time Frame: 1, 2, 5 and 10 years
|
Blood lipids include total, LDL- and HDL-cholesterol and triglyceride
|
1, 2, 5 and 10 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical activity levels
Time Frame: 1, 2, 5 and 10 years
|
Physical activity levels assessed using the global physical activity questionnaire (GPAQ)
|
1, 2, 5 and 10 years
|
Diet
Time Frame: 1, 2, 5 and 10 years
|
Diet assessed by 24 hour food recall
|
1, 2, 5 and 10 years
|
Prevalence of current smokers
Time Frame: 1, 2, 5 and 10 years
|
Percentage of current smokers in the study samples
|
1, 2, 5 and 10 years
|
Prevalence of alcohol consumption
Time Frame: 1, 2, 5 and 10 years
|
Percentage of those who report alcohol consumption
|
1, 2, 5 and 10 years
|
Cognitive function
Time Frame: 2, 5 and 10 years
|
Cognitive function assessed by MMSE score
|
2, 5 and 10 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Prasert Boongird, MD, Dementia Association of Dementia
- Principal Investigator: Parinya Chamnan, MD, PhD, Sanpasitthiprasong Hospital
- Principal Investigator: Wannee Nitiyanant, MD, Siriraj Hospital
- Principal Investigator: Wichai Aekplakorn, MD, PhD, Ramathibodi Hospital, Mahidol University
- Principal Investigator: Chanida Pachotikarn, PhD, Thai Dietetic Society
- Principal Investigator: Chaicharn Deerochanawong, MD, Rajvithi Hospital
- Principal Investigator: Surasak Kantachuvesiri, MD, PhD, Ramathibodi Hospital, Mahidol University
- Principal Investigator: Wallaya Jongjaroenprasert, MD, Ramathibodi Hospital, Mahidol University
- Principal Investigator: Atiporn Ingsathit, MD, PhD, Ramathibodi Hospital, Mahidol University
- Principal Investigator: Win Techakehakij, MD, PhD, Lampang Hospital
- Principal Investigator: Phanida Krittayapoositpot, MD, Dementia Association of Thailand
- Principal Investigator: Worawan Chailimpamontri, MD, Bhumibol Adulyadej Hospital
- Principal Investigator: Ampika Mangklabruks, MD, Faculty of medicine, Chiangmai University
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Glucose Metabolism Disorders
- Metabolic Diseases
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Respiratory Tract Diseases
- Urologic Diseases
- Neurocognitive Disorders
- Endocrine System Diseases
- Renal Insufficiency
- Cardiovascular Diseases
- Diabetes Mellitus
- Kidney Diseases
- Renal Insufficiency, Chronic
- Lung Diseases
- Lung Diseases, Obstructive
- Pulmonary Disease, Chronic Obstructive
- Dementia
Other Study ID Numbers
- CMR-571
- HSRI 59-069 (Other Grant/Funding Number: Health System Research Institute)
- TCTR20161116001 (Registry Identifier: Thai Clinical Trials Registry)
- 59-00-0228 (Other Grant/Funding Number: Thai Health Promotion Foundation)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinActive, not recruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
Nanjing Medical UniversityRecruiting
-
Centre Hospitalier Universitaire de la RéunionRecruitingCardiovascular DiseaseFrance
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular DiseaseUnited States
Clinical Trials on 4 x 4 lifestyle modification
-
Universität Duisburg-EssenUniversity of Witten/HerdeckeCompletedChronic PainGermany
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompleted
-
Hospices Civils de LyonCompleted
-
University of NebraskaCompleted
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Assiut UniversityUnknownChronic Lymphocytic Leukemia
-
University of OuluOulu University Hospital; Oulu Deaconess Institute Foundation srCompletedObesity | Physical Activity | Weight Loss | Healthy Obesity, MetabolicallyFinland
-
University of PennsylvaniaSt. Luke's-Roosevelt Hospital CenterCompletedObesity | OverweightUnited States
-
Clínica BazterricaWithdrawn
-
Universität Duisburg-EssenCharite University, Berlin, Germany; University of Witten/Herdecke; Kliniken... and other collaboratorsCompletedHypertension | Metabolic SyndromeGermany